CoChat

The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia

Open access
Sacks, Frank M. · 2015 · Current Opinion in Lipidology

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Abstract

PURPOSE OF REVIEW: To describe the roles of apolipoprotein C-III (apoC-III) and apoE in VLDL and LDL metabolism RECENT FINDINGS: ApoC-III can block clearance from the circulation of apolipoprotein B (apoB) lipoproteins, whereas apoE mediates their clearance. Normolipidemia is sustained by hepatic secretion of VLDL and IDL subspecies that contain both apoE and apoC-III (VLDL E+C-III+). Most of this VLDL E+C-III+ is speedily lipolyzed, reduced in apoC-III content, and cleared from the circulation as apoE containing dense VLDL, IDL, and light LDL. In contrast, in hypertriglyceridemia, most VLDL is secreted with apoC-III but without apoE, and so it is not cleared until it loses apoC-III during lipolysis to dense LDL. In normolipidemia, the liver also secretes IDL and large and medium-size LDL, whereas in hypertriglyceridemia, the liver secretes more dense LDL with and without apoC-III. These pathways establish the hypertriglyceridemic phenotype and link it metabolically to dense LDL. Dietary carbohydrate compared with unsaturated fat suppresses metabolic pathways mediated by apoE that are qualitatively similar to those suppressed in hypertriglyceridemia. SUMMARY: The opposing actions of apoC-III and apoE on subspecies of VLDL and LDL, and the direct secretion of LDL in several sizes, establish much of the basic structure of human apoB lipoprotein metabolism in normal and hypertriglyceridemic humans.

Overview

Integrity signals

Registry

Crossref · 10.1097/mol.0000000000000146

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 51 references

Research works printed but not linked: 1

  1. Sundaram, 2010, J Lipid Res, 51, 150, 10.1194/m900346-jlr200 · doi:10.1194/m900346-jlr200 · Paper page

Cited by

See all 179

Metadata

Authors
Sacks, F. M.
Affiliations
Harvard University (US)
Corresponding author
Sacks, Frank M.
Venue
Current Opinion in Lipidology
Published
2015-02
Volume
26
Issue
1
Pages
56-63
ISSN
0957-9672 (ISSN-L)
OpenAlex
W2054345063
Cited by
168
References
51
Citations by year
2026: 3 · 2025: 13 · 2024: 7 · 2023: 10 · 2022: 11 · 2021: 25 · 2020: 22 · 2019: 24 · 2018: 17 · 2017: 11 · 2016: 14 · 2015: 11
FWCI
1.93
Type
journal article
Language
en
Open access
Locations
  • Current Opinion in Lipidology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Funders
  • AstraZeneca
  • Harvard University
  • National Heart, Lung, and Blood Institute (R01HL069376, R01HL070159)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Keywords
apolipoprotein E, apolipoprotein C-III, VLDL metabolism, LDL metabolism, lipoprotein clearance, hypertriglyceridemia, lipolysis, hepatic lipoprotein secretion, dietary carbohydrates, unsaturated fat
MeSH terms
Animals, Apolipoproteins B, Apolipoproteins E, Diet, Humans, Lipoprotein Lipase, Hypertriglyceridemia, Apolipoprotein C-III

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia. https://app.cochat.ai/papers/10.1097/mol.0000000000000146
The paper
Sacks, F. M. (2015). The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia. Current Opinion in Lipidology. https://doi.org/10.1097/mol.0000000000000146

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.